Latest Blog Posts Tagged "Inhalant"
February 09, 2017
Pharmaceutical company Acorda reported positive results from a Phase III trial of an inhaled form of levodopa to treat "off" periods in Parkinson's.
November 21, 2013
Unpredictable on/off periods can greatly interfere with daily life, and are perhaps the major concern for today's patients. That's why MJFF is hard at work to improve existing treatments.
June 18, 2013
Dave Iverson speaks with the CEO of Civitas, Glenn Batchelder, and MJFF staffer Maurizio Facheris, MD, MSc to learn more about how the drug works, as well as next steps.
A Breath of Relief: Inhaled Formulation of Levodopa Reduces 'Off' Periods in People with Parkinson's
April 19, 2013
Chelsea, Massachusetts-based biotech Civitas Therapeutics announced positive clinical trial results for their inhaled formulation of levodopa, called CVT-301.